Average Co-Inventor Count = 3.81
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Emisphere Technologies, Inc. (9 from 183 patents)
2. Novo Nordisk North America Operations A/s (1 from 2 patents)
10 patents:
1. 11395809 - Crystalline polymorphic forms of monosodium n-[-8-(2-hydroxybenzoyl)amino]caprylate
2. 10744105 - Crystalline polymorphic forms of monosodium N-[-8-(2-hydroxybenzoyl)amino]caprylate
3. 10188621 - Crystalline polymorphic forms of monosodium N-[-8-(2-hydroxybenzoyl)amino]caprylate
4. 9750710 - Crystalline polymorphic forms of monosodium N-[-8-(2-hydroxybenzoyl)amino]caprylate
5. 9321719 - Crystalline polymorphic forms of monosodium N-[-8-(2-hydroxybenzoyl)amino]caprylate
6. 8927015 - Formulations for delivering insulin
7. 8636996 - Crystalline polymorphic forms of monosodium N-[-8-(2-hydroxybenzoyl)amino]caprylate
8. 7462368 - Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino]butanoate
9. 7420085 - Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino] butanoate
10. 7227033 - Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino] butanoate